Example: Heart Attack

Clinical Trials on Fibrinogen Deficiency, Congenital

Total 10 results

NCT03793426

Not yet recruiting

Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency

Conditions: Congenital Fibrinogen Deficiency
NCT02427217

Completed

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

Conditions: Congenital Fibrinogen Deficiency
NCT02408484

Completed

Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency

Conditions: Congenital Fibrinogen Deficiency
NCT02267226

Completed

Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

Conditions: Congenital Fibrinogen Deficiency
NCT01575756

Completed

Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

Conditions: Congenital Fibrinogen Deficiency; Afibrinogenemia
NCT02094430

Completed

Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

Conditions: Hypofibrinogenemia, Congenital; Afibrinogenemia, Congenital
NCT02065882

Recruiting

Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen Deficiency

Conditions: Congenital Afibrinogenemia; Congenital Hypofibrinogenemia
NCT00916656

Withdrawn

Fibrinogen Concentrate (Human) - Efficacy and Safety Study

Conditions: Afibrinogenemia; Hypofibrinogenemia; Fibrinogen Deficiency
NCT00496262

Completed

Human Fibrinogen - Pharmacokinetics

Conditions: Fibrinogen Deficiency
NCT03920332

Recruiting

Pregnancy and Fibrinogen Disorders

Conditions: Hypofibrinogenemia, Congenital; Afibrinogenemia, Congenital; Dysfibrinogenemia, Congenital